A neuronal function of the tumor suppressor protein merlin

Mutagenic loss of the NF2 tumor suppressor gene encoded protein merlin is known to provoke the hereditary neoplasia syndrome, Neurofibromatosis type 2 (NF2). In addition to glial cell-derived tumors in the PNS and CNS, disease-related lesions also affect the skin and the eyes. Furthermore, 60% of NF2 patients suffer from peripheral nerve damage, clinically referred to as peripheral neuropathy. Strikingly, NF2-associated neuropathy often occurs in the absence of nerve damaging tumors, suggesting tumor-independent events. Recent findings indicate an important role of merlin in neuronal cell types concerning neuromorphogenesis, axon structure maintenance and communication between axons and Schwann cells. In this review, we compile clinical and experimental evidences for the underestimated role of the tumor suppressor merlin in the neuronal compartment.

• Publication year

  2014

• Venue

  Acta Neuropathologica Communications

• Publication date

  2014-07-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1186/s40478-014-0082-1PMID 25012216PMCID 4149232
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Peripheral Neuropathy

  2019cited by this paper
• In Vivo Functional Analysis of the Human NF2 Tumor Suppressor Gene in Drosophila

  2014cited by this paper
• Membrane domain organization of myelinated axons requires βII spectrin

  2013cited by this paper
• Neuronal merlin influences ERBB2 receptor expression on Schwann cells through neuregulin 1 type III signalling

  2013influential reference
• Merlin isoform 2 in neurofibromatosis type 2–associated polyneuropathy

  2013influential reference
• Tumor suppressor Nf2 limits expansion of the neural progenitor pool by inhibiting Yap/Taz transcriptional coactivators

  2013cited by this paper
• Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2.

  2013cited by this paper
• Merlin: a tumour suppressor with functions at the cell cortex and in the nucleus

  2012cited by this paper
• Accumulation of non-compressive fascicular lesions underlies NF2 polyneuropathy

  2012cited by this paper
• Distinct overlapping sequences at the carboxy-terminus of merlin regulate its tumour suppressor and morphogenic activity

  2012cited by this paper
• Dendritic spine pathology in neuropsychiatric disorders

  2011cited by this paper
• Local, persistent activation of Rho GTPases during plasticity of single dendritic spines

  2011cited by this paper
• The role of neuregulin-1 in the response to nerve injury.

  2011cited by this paper
• What Is the Site of Origin of Cochleovestibular Schwannomas?

  2011cited by this paper
• FERM Domain Phosphoinositide Binding Targets Merlin to the Membrane and Is Essential for Its Growth-Suppressive Function

  2011cited by this paper
• Schwannomin/merlin promotes Schwann cell elongation and influences myelin segment length.

  2011cited by this paper
• Merlin Inhibits Neurite Outgrowth in the CNS

  2010influential reference
• Regulation of Mixed Lineage Kinase 3 is Required for Neurofibromatosis-2-Mediated Growth Suppression in Human Cancer

  2010cited by this paper
• Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas

  2010cited by this paper
• Neurofibromatosis 2 with peripheral neuropathies: Electrophysiological, pathological and genetic studies of a Taiwanese family

  2010cited by this paper
• Merlin/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus.

  2010cited by this paper
• ErbB/HER receptor activation and preclinical efficacy of lapatinib in vestibular schwannoma.

  2010cited by this paper
• Identification of Erythrocyte p55/MPP1 as a Binding Partner of NF2 Tumor Suppressor Protein/Merlin

  2009cited by this paper
• 軸索型多発ニューロパチーを契機として診断にいたった高齢発症の神経線維腫症2型（NF2）の1例

  2009cited by this paper
• Consensus Recommendations to Accelerate Clinical Trials for Neurofibromatosis Type 2

  2009cited by this paper
• [A case of neurofibromatosis type 2 (NF2) presenting with late-onset axonal polyneuropathy].

  2009cited by this paper
• Merlin and the ERM proteins--regulators of receptor distribution and signaling at the cell cortex.

  2009cited by this paper
• Neurofibromatosis type 2.

  2009cited by this paper
• NF2/Merlin Is a Novel Negative Regulator of mTOR Complex 1, and Activation of mTORC1 Is Associated with Meningioma and Schwannoma Growth

  2009cited by this paper
• Merlin regulates transmembrane receptor accumulation and signaling at the plasma membrane in primary mouse Schwann cells and in human schwannomas

  2009cited by this paper
• Rho-linked genes and neurological disorders

  2008cited by this paper
• The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells.

  2008cited by this paper
• Neuregulin and laminin stimulate phosphorylation of the NF2 tumor suppressor in Schwann cells by distinct protein kinase A and p21-activated kinase-dependent pathways

  2008cited by this paper
• Molecular domains of myelinated axons in the peripheral nervous system

  2008cited by this paper
• Tumor Suppressor Schwannomin/Merlin Is Critical for the Organization of Schwann Cell Contacts in Peripheral Nerves

  2008cited by this paper
• The ErbB Inhibitors Trastuzumab and Erlotinib Inhibit Growth of Vestibular Schwannoma Xenografts in Nude Mice: A Preliminary Study

  2008cited by this paper
• Magic but treatable? Tumours due to loss of merlin.

  2008cited by this paper
• Review of the Multiple Aspects of Neurofilament Functions, and their Possible Contribution to Neurodegeneration

  2008cited by this paper
• The merlin interacting proteins reveal multiple targets for NF2 therapy.

  2008cited by this paper
• Neurofibromatosis 2 tumor suppressor, the gene induced by valproic acid, mediates neurite outgrowth through interaction with paxillin.

  2008cited by this paper
• NF1 loss disrupts Schwann cell-axonal interactions: a novel role for semaphorin 4F.

  2008cited by this paper
• Merlin/neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac.

  2007cited by this paper
• Neurofibromatosis type 2

  2007cited by this paper
• The tumor suppressor merlin interacts with microtubules and modulates Schwann cell microtubule cytoskeleton.

  2007cited by this paper
• The Nf2 tumor suppressor regulates cell–cell adhesion during tissue fusion

  2007cited by this paper
• Actin-Rich Protrusions and Nonlocalized GTPase Activation in Merlin-Deficient Schwannomas

  2007cited by this paper
• Role of NF2 Haploinsufficiency in NF2‐associated Polyneuropathy

  2007influential reference
• Overexpression of ErbB2 and ErbB3 receptors in Schwann cells of patients with Charcot–Marie–Tooth disease type 1A

  2006cited by this paper
• [Expression of Merlin in cortex of temporal lobe and in hippocampal CA1 region of the Kindling Model of Epilepsy induced by corciaria lactone in rats].

  2006cited by this paper
• The origin and development of glial cells in peripheral nerves

  2005cited by this paper
• The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2

  2005cited by this paper
• Characterization of the NF2 protein merlin and the ERM protein ezrin in human, rat, and mouse central nervous system.

  2005cited by this paper
• Cell cycle-dependent nucleocytoplasmic shuttling of the neurofibromatosis 2 tumour suppressor merlin

  2005cited by this paper
• Neuregulin-1 type III determines the ensheathment fate of axons.

  2005cited by this paper
• Evolution and origin of merlin, the product of the Neurofibromatosis type 2 (NF2) tumor-suppressor gene

  2005cited by this paper
• The search for autism disease genes.

  2004cited by this paper
• Peripheral neuropathy.

  2004cited by this paper
• Mechanisms and Roles of Axon-Schwann Cell Interactions

  2004cited by this paper
• Merlin and the ERM proteins in Schwann cells, neurons and growth cones

  2004cited by this paper
• Axonal Neuregulin-1 Regulates Myelin Sheath Thickness

  2004cited by this paper
• Association of Caspr/paranodin with tumour suppressor schwannomin/merlin and β1 integrin in the central nervous system

  2003influential reference
• Merlin Links to the cAMP Neuronal Signaling Pathway by Anchoring the RIβ Subunit of Protein Kinase A*

  2003cited by this paper
• The deaf and the dumb: the biology of ErbB-2 and ErbB-3.

  2003cited by this paper
• Neurofibromatosis 2

  2003cited by this paper
• Occurrence and characterization of peripheral nerve involvement in neurofibromatosis type 2.

  2002cited by this paper
• ERM proteins and merlin: integrators at the cell cortex

  2002cited by this paper
• Polyneuropathy in neurofibromatosis 2: clinical findings, molecular genetics and neuropathological alterations in sural nerve biopsy specimens

  2002cited by this paper
• The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44.

  2001influential reference
• Glial Growth Factor/Neuregulin Inhibits Schwann Cell Myelination and Induces Demyelination

  2001cited by this paper
• Workshop Egyptox-2000: for better environmental education by the birth of the new millennium.

  2001cited by this paper
• Schwannomin Isoform-1 Interacts with Syntenin via PDZ Domains*

  2001cited by this paper
• The neurofibromatosis 2 protein product merlin selectively binds F-actin but not G-actin, and stabilizes the filaments through a lateral association.

  2001cited by this paper
• A novel isoform of beta-spectrin II localizes to cerebellar Purkinje-cell bodies and interacts with neurofibromatosis type 2 gene product schwannomin

  2001cited by this paper
• Mononeuropathy multiplex as the initial manifestation of neurofibromatosis type 2

  2001cited by this paper
• RHO GTPASES in neuronal morphogenesis

  2000cited by this paper
• Interaction between two isoforms of the NF2 tumor suppressor protein, merlin, and between merlin and ezrin, suggests modulation of ERM proteins by merlin

  2000cited by this paper
• Cd44 Enhances Neuregulin Signaling by Schwann Cells

  2000cited by this paper
• The neurofibromatosis 2 tumor suppressor protein interacts with hepatocyte growth factor-regulated tyrosine kinase substrate.

  2000cited by this paper
• Expression level, subcellular distribution and Rho-GDI binding affinity of merlin in comparison with ezrin/radixin/moesin proteins

  1999cited by this paper
• Increased expression of the NF2 tumor suppressor gene product, merlin, impairs cell motility, adhesionand spreading.

  1999cited by this paper
• Novel alternatively spliced isoforms of the neurofibromatosis type 2 tumor suppressor are targeted to the nucleus and cytoplasmic granules.

  1999cited by this paper
• Expression of the Neurofibromatosis Type 2 Gene in Human Tissues

  1999cited by this paper
• Neurofibromatosis 2 tumour suppressor schwannomin interacts with βII-spectrin

  1998influential reference
• Schwann cell proliferation as the cause of peripheral neuropathy in neurofibromatosis-2.

  1998cited by this paper
• Clinical Aspects

  1998cited by this paper
• Type II neurofibromatosis presenting as quadriceps atrophy

  1998cited by this paper
• G Proteins and Small GTPases: Distant Relatives Keep in Touch

  1998cited by this paper
• Loss of the NF2 gene and merlin occur by the tumorlet stage of schwannoma development in neurofibromatosis 2.

  1998cited by this paper
• Merlin differentially associates with the microtubule and actin cytoskeleton

  1998cited by this paper
• Interdomain binding mediates tumor growth suppression by the NF2 gene product

  1997cited by this paper
• Expression of NF2-encoded merlin and related ERM family proteins in the human central nervous system.

  1997cited by this paper
• The Nf2 tumor suppressor gene product is essential for extraembryonic development immediately prior to gastrulation.

  1997cited by this paper
• Reduced expression of schwannomin/merlin in human sporadic meningiomas.

  1997cited by this paper
• Axon–Schwann cell interactions during peripheral nerve degeneration and regeneration

  1997cited by this paper
• Frequency and distribution of NF2 mutations in schwannomas

  1996cited by this paper
• Expression of neurofibromatosis 2 transcript and gene product during mouse fetal development.

  1996cited by this paper
• Neurofibromatosis type 2 in an adolescent boy with polyneuropathy and a mutation in the NF2 gene

  1996cited by this paper
• Expression of the neurofibromatosis 2 (NF2) gene isoforms during rat embryonic development.

  1995influential reference
• A genetic test of the effects of mutations in PKA on mossy fiber LTP and its relation to spatial and contextual learning.

  1995cited by this paper
• Widespread but cell type-specific expression of the mouse neurofibromatosis type 2 gene

  1995cited by this paper

• Modulating PAK1: Accessory Proteins as Promising Therapeutic Targets

  2025cites this paper
• Metastasis Associated in Colorectal Cancer 1 (MACC1) mRNA Expression Is Enhanced in Sporadic Vestibular Schwannoma and Correlates to Deafness

  2023cites this paper
• TIMAP, a Regulatory Subunit of Protein Phosphatase 1, Inhibits In Vitro Neuronal Differentiation

  2023cites this paper
• ADAM9: A novel player in vestibular schwannoma pathogenesis

  2020cites this paper
• Neurofibromatosis 2

  2020cites this paper
• A Functional Interaction Between Na,K-ATPase β2-Subunit/AMOG and NF2/Merlin Regulates Growth Factor Signaling in Cerebellar Granule Cells

  2019cites this paper
• [68Ga]-Pentixafor PET/CT for CXCR4-Mediated Imaging of Vestibular Schwannomas

  2019cites this paper
• Estudio Genómico de Schwannomas Esporádicos y Schwannomas asociados a Neurofibromatosis tipo 2

  2019cites this paper
• From process to progress—2017 International Conference on Neurofibromatosis 1, Neurofibromatosis 2 and Schwannomatosis

  2019cites this paper
• CXCR4: A new player in vestibular schwannoma pathogenesis

  2018cites this paper
• Nf2 Mutation in Schwann Cells Delays Functional Neural Recovery Following Injury.

  2018influential citation
• Neuropathies in the setting of Neurofibromatosis tumor syndromes: Complexities and opportunities

  2018cites this paper
• Mammalian Sterile20-like Kinases: Signalings and Roles in Central Nervous System

  2018cites this paper
• Immunohistochemical Markers for Schwannomas, Neurofibromas and Malignant Peripheral Nerve Sheath Tumors—What Can the Recent Literature Tell Us?

  2018cites this paper
• Neurofibromatosis as a gateway to better treatment for a variety of malignancies

  2017cites this paper
• Muscle action potential scans and ultrasound imaging in neurofibromatosis type 2

  2017cites this paper
• Neurinoma del acústico bilateral como diagnóstico de neurofibromatosis tipo 2: reporte de caso clínico

  2017cites this paper
• Characterization of Hippo Pathway Components by Gene Inactivation.

  2016cites this paper
• The importance of nerve microenvironment for schwannoma development

  2016cites this paper
• Neuron-Specific Deletion of the Nf2 Tumor Suppressor Impairs Functional Nerve Regeneration

  2016cites this paper
• The Caenorhabditis elegans NF2/Merlin Molecule NFM-1 Nonautonomously Regulates Neuroblast Migration and Interacts Genetically with the Guidance Cue SLT-1/Slit

  2016cites this paper
• Expression and significance of Hippo/YAP signaling in glioma progression

  2016cites this paper
• The C. elegans NF2/Merlin Molecule NFM-1 Non-Autonomously Regulates Neuroblast Migration and Interacts Genetically with the Guidance Cue SLT-1/Slit

  2016cites this paper
• [Molecular genetics of familial tumour syndromes of the central nervous system].

  2015cites this paper
• Role of Merlin/NF2 Inactivation in Tumor Biology

  2015cites this paper
• Disease implications of the Hippo/YAP pathway.

  2015cites this paper
• The importance of nerve microenvironment for schwannoma The importance of nerve microenvironment for schwannoma development development

  year unknowncites this paper